141 related articles for article (PubMed ID: 9443936)
21. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.
Bennett MR; Anglin S; McEwan JR; Jagoe R; Newby AC; Evan GI
J Clin Invest; 1994 Feb; 93(2):820-8. PubMed ID: 8113414
[TBL] [Abstract][Full Text] [Related]
22. Anti-proliferative effects of unmodified antisense oligodeoxynucleotides targeted against c-raf mRNA: use of poly (lysine/serine) copolymers or cationic lipopolyamines.
Aoki Y; Kawa S; Karasawa Y; Horiuchi A; Kiyosawa K
Clin Exp Pharmacol Physiol; 1998 Sep; 25(9):702-5. PubMed ID: 9750959
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activity of a PKC-alpha antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted into nude mice.
Geiger T; Müller M; Dean NM; Fabbro D
Anticancer Drug Des; 1998 Jan; 13(1):35-45. PubMed ID: 9474241
[TBL] [Abstract][Full Text] [Related]
24. Anti-tumor activity of C-raf antisense--correction.
Monia BP
Nat Med; 1999 Feb; 5(2):127. PubMed ID: 9930845
[No Abstract] [Full Text] [Related]
25. Abrogation of c-Raf expression induces apoptosis in tumor cells.
Lau QC; Brüsselbach S; Müller R
Oncogene; 1998 Apr; 16(14):1899-902. PubMed ID: 9583688
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.
Dean N; McKay R; Miraglia L; Howard R; Cooper S; Giddings J; Nicklin P; Meister L; Ziel R; Geiger T; Muller M; Fabbro D
Cancer Res; 1996 Aug; 56(15):3499-507. PubMed ID: 8758918
[TBL] [Abstract][Full Text] [Related]
27. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
[TBL] [Abstract][Full Text] [Related]
28. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.
Morishita R; Gibbons GH; Ellison KE; Nakajima M; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8474-8. PubMed ID: 8104336
[TBL] [Abstract][Full Text] [Related]
29. Regulation of vascular smooth muscle cell insulin-like growth factor I receptors by phosphorothioate oligonucleotides. Effects on cell growth and evidence that sense targeting at the ATG site increases receptor expression.
Delafontaine P; Meng XP; Ku L; Du J
J Biol Chem; 1995 Jun; 270(24):14383-8. PubMed ID: 7782298
[TBL] [Abstract][Full Text] [Related]
30. Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancer.
McPhillips F; Mullen P; Monia BP; Ritchie AA; Dorr FA; Smyth JF; Langdon SP
Br J Cancer; 2001 Nov; 85(11):1753-8. PubMed ID: 11742498
[TBL] [Abstract][Full Text] [Related]
31. Growth-related responses in arterial smooth muscle cells are arrested by thrombin receptor antisense sequences.
Chaikof EL; Caban R; Yan CN; Rao GN; Runge MS
J Biol Chem; 1995 Mar; 270(13):7431-6. PubMed ID: 7706289
[TBL] [Abstract][Full Text] [Related]
32. Antisense raf oligodeoxyribonucleotide is a radiosensitizer in vivo.
Gokhale PC; McRae D; Monia BP; Bagg A; Rahman A; Dritschilo A; Kasid U
Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):191-201. PubMed ID: 10355825
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Raf-1 protein kinase by antisense phosphorothioate oligodeoxyribonucleotide is associated with sensitization of human laryngeal squamous carcinoma cells to gamma radiation.
Soldatenkov VA; Dritschilo A; Wang FH; Olah Z; Anderson WB; Kasid U
Cancer J Sci Am; 1997; 3(1):13-20. PubMed ID: 9072302
[TBL] [Abstract][Full Text] [Related]
34. Focal adhesion kinase antisense oligodeoxynucleotides inhibit human pulmonary artery smooth muscle cells proliferation and promote human pulmonary artery smooth muscle cells apoptosis.
Lin CL; Zhang ZX; Xu YJ; Ni W; Chen SX
Chin Med J (Engl); 2005 Jan; 118(1):20-6. PubMed ID: 15642221
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration.
Biro S; Fu YM; Yu ZX; Epstein SE
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):654-8. PubMed ID: 8421701
[TBL] [Abstract][Full Text] [Related]
36. Effect of methylene methylimino linkage of antisense oligonucleotide to the platelet-derived growth factor A-chain on growth of vascular smooth muscle cells from spontaneously hypertensive rats.
Kishioka H; Fukuda N; Nakayama M; Hu WY; Satoh C; Kanmatsuse K; Bhat B; Symons AM
Eur J Pharmacol; 2000 Mar; 392(3):129-32. PubMed ID: 10762664
[TBL] [Abstract][Full Text] [Related]
37. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
Broaddus WC; Chen ZJ; Prabhu SS; Loudon WG; Gillies GT; Phillips LL; Fillmore H
Neurosurgery; 1997 Oct; 41(4):908-15. PubMed ID: 9316053
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of smooth muscle cell proliferation by an antisense oligodeoxynucleotide targeting the messenger RNA encoding proliferating cell nuclear antigen.
Speir E; Epstein SE
Circulation; 1992 Aug; 86(2):538-47. PubMed ID: 1353419
[TBL] [Abstract][Full Text] [Related]
39. Antisense oligonucleotides: target validation and development of systemically delivered therapeutic nanoparticles.
Zhang C; Pei J; Kumar D; Sakabe I; Boudreau HE; Gokhale PC; Kasid UN
Methods Mol Biol; 2007; 361():163-85. PubMed ID: 17172711
[TBL] [Abstract][Full Text] [Related]
40. Transfer of antisense oligodeoxynucleotides against endothelin receptors A and B into human coronary smooth muscle cells and endothelial cells by apolipoprotein E peptide: an in vitro study.
Miura S; Okamoto T; Via DP; Saku K
Circ J; 2002 Nov; 66(11):1054-6. PubMed ID: 12419939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
